Emre Can Tüysüz

423 total citations
19 papers, 302 citations indexed

About

Emre Can Tüysüz is a scholar working on Molecular Biology, Cancer Research and Rheumatology. According to data from OpenAlex, Emre Can Tüysüz has authored 19 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Rheumatology. Recurrent topics in Emre Can Tüysüz's work include Bone Tumor Diagnosis and Treatments (6 papers), MicroRNA in disease regulation (5 papers) and Sarcoma Diagnosis and Treatment (4 papers). Emre Can Tüysüz is often cited by papers focused on Bone Tumor Diagnosis and Treatments (6 papers), MicroRNA in disease regulation (5 papers) and Sarcoma Diagnosis and Treatment (4 papers). Emre Can Tüysüz collaborates with scholars based in Türkiye, Sweden and United States. Emre Can Tüysüz's co-authors include Ömer Faruk Bayrak, Şükrü Güllüoğlu, Fikrettin Şahιn, Cumhur Kaan Yaltırık, Uğur Türe, Altay Burak Dalan, Ayşegül Doğan, Selami Demirci, Oleg Gusev and Ferda Özkan and has published in prestigious journals such as Scientific Reports, Brain Research and Developmental Biology.

In The Last Decade

Emre Can Tüysüz

19 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emre Can Tüysüz Türkiye 11 138 97 50 43 41 19 302
Feilan Chen China 10 211 1.5× 114 1.2× 50 1.0× 53 1.2× 40 1.0× 25 410
Wang Tang China 10 177 1.3× 57 0.6× 63 1.3× 43 1.0× 14 0.3× 13 309
Maya Fakhry Lebanon 5 177 1.3× 77 0.8× 59 1.2× 30 0.7× 21 0.5× 6 354
Chenchen Ji China 10 155 1.1× 97 1.0× 29 0.6× 23 0.5× 30 0.7× 25 314
Karina Galoian United States 12 174 1.3× 96 1.0× 73 1.5× 27 0.6× 93 2.3× 26 348
Yunshu Che China 9 172 1.2× 72 0.7× 39 0.8× 44 1.0× 11 0.3× 16 284
Wanqing Xie China 11 145 1.1× 43 0.4× 85 1.7× 26 0.6× 24 0.6× 19 304
Yuning J. Tang United States 9 192 1.4× 83 0.9× 44 0.9× 70 1.6× 46 1.1× 20 322
Chengyu Lv China 12 162 1.2× 62 0.6× 33 0.7× 54 1.3× 38 0.9× 28 382
Yuko Nariai Japan 13 243 1.8× 49 0.5× 30 0.6× 86 2.0× 27 0.7× 28 455

Countries citing papers authored by Emre Can Tüysüz

Since Specialization
Citations

This map shows the geographic impact of Emre Can Tüysüz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emre Can Tüysüz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emre Can Tüysüz more than expected).

Fields of papers citing papers by Emre Can Tüysüz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emre Can Tüysüz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emre Can Tüysüz. The network helps show where Emre Can Tüysüz may publish in the future.

Co-authorship network of co-authors of Emre Can Tüysüz

This figure shows the co-authorship network connecting the top 25 collaborators of Emre Can Tüysüz. A scholar is included among the top collaborators of Emre Can Tüysüz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emre Can Tüysüz. Emre Can Tüysüz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Olsson, Robin, Emre Can Tüysüz, Maja Karlsson, et al.. (2025). Neuronal CD59 isoforms IRIS-1 and IRIS-2 as regulators of neurotransmitter release with implications for Alzheimer’s disease. Alzheimer s Research & Therapy. 17(1). 11–11. 2 indexed citations
2.
Leandersson, Karin, David O’Connell, Valeria Governa, et al.. (2024). Complement Factor H Is an ICOS Ligand Modulating Tregs in the Glioma Microenvironment. Cancer Immunology Research. 13(1). 122–138. 4 indexed citations
3.
Tüysüz, Emre Can, Chrysostomi Gialeli, Valeria Governa, et al.. (2024). Tumor suppressor role of the complement inhibitor CSMD1 and its role in TNF-induced neuroinflammation in gliomas. Journal of Experimental & Clinical Cancer Research. 43(1). 98–98. 5 indexed citations
4.
Tüysüz, Emre Can, et al.. (2023). Impact of silencing eEF2K expression on the malignant properties of chordoma. Molecular Biology Reports. 50(4). 3011–3022. 1 indexed citations
5.
Gialeli, Chrysostomi, Emre Can Tüysüz, Johan Staaf, et al.. (2021). Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy. Journal of Experimental & Clinical Cancer Research. 40(1). 258–258. 13 indexed citations
6.
Tüysüz, Emre Can, et al.. (2021). miRNAs as cell fate determinants of lateral and paraxial mesoderm differentiation from embryonic stem cells. Developmental Biology. 478. 212–221. 6 indexed citations
7.
Tüysüz, Emre Can, et al.. (2021). Small molecule‐mediated modulation of ubiquitination and neddylation improves HSC function ex vivo. Journal of Cellular Physiology. 236(12). 8122–8136. 8 indexed citations
8.
Doğan, Soner, Işın Doğan Ekici, Bayram Yılmaz, et al.. (2021). Roles of adiponectin and leptin signaling-related microRNAs in the preventive effects of calorie restriction in mammary tumor development. Applied Physiology Nutrition and Metabolism. 46(8). 866–876. 9 indexed citations
9.
Aslan, Galip Servet, et al.. (2020). Development of Small Molecule MEIS Inhibitors that modulate HSC activity. Scientific Reports. 10(1). 7994–7994. 26 indexed citations
10.
Güllüoğlu, Şükrü, Emre Can Tüysüz, Cumhur Kaan Yaltırık, et al.. (2019). The role of TNF-α in chordoma progression and inflammatory pathways. Cellular Oncology. 42(5). 663–677. 27 indexed citations
11.
Tüysüz, Emre Can, Şükrü Güllüoğlu, Cumhur Kaan Yaltırık, et al.. (2019). Distinctive role of dysregulated miRNAs in chordoma cancer stem-like cell maintenance. Experimental Cell Research. 380(1). 9–19. 12 indexed citations
12.
Tüysüz, Emre Can, Cumhur Kaan Yaltırık, Ferda Özkan, et al.. (2019). Co-polysomy of 1p/19q in glial tumors: Retrospective analysis of 221 cases from single center. Gene. 701. 161–168. 2 indexed citations
13.
Güllüoğlu, Şükrü, Emre Can Tüysüz, Cumhur Kaan Yaltırık, et al.. (2018). Simultaneous miRNA and mRNA transcriptome profiling of glioblastoma samples reveals a novel set of OncomiR candidates and their target genes. Brain Research. 1700. 199–210. 33 indexed citations
14.
Aslan, Galip Servet, et al.. (2018). c-Myc Inhibitor 10074-G5 Induces Murine and Human Hematopoietic Stem and Progenitor Cell Expansion and HDR Modulator Rad51 Expression. Current Cancer Drug Targets. 19(6). 479–494. 26 indexed citations
15.
Demirci, Selami, Ayşegül Doğan, Emre Can Tüysüz, et al.. (2017). Cytoglobin inhibits migration through PI3K/AKT/mTOR pathway in fibroblast cells. Molecular and Cellular Biochemistry. 437(1-2). 133–142. 21 indexed citations
16.
Doğan, Ayşegül, Selami Demirci, Ömer Faruk Bayrak, et al.. (2017). A new hope for obesity management: Boron inhibits adipogenesis in progenitor cells through the Wnt/β-catenin pathway. Metabolism. 69. 130–142. 45 indexed citations
17.
Dalan, Altay Burak, Şükrü Güllüoğlu, Emre Can Tüysüz, et al.. (2017). Simultaneous analysis of miRNA-mRNA in human meningiomas by integrating transcriptome: A relationship between PTX3 and miR-29c. BMC Cancer. 17(1). 207–207. 27 indexed citations
18.
Güllüoğlu, Şükrü, Emre Can Tüysüz, Cumhur Kaan Yaltırık, et al.. (2017). Leukemia Inhibitory Factor Promotes Aggressiveness of Chordoma. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 25(7). 1177–1188. 22 indexed citations
19.
Güllüoğlu, Şükrü, Emre Can Tüysüz, Uğur Türe, et al.. (2016). The potential function of microRNA in chordomas. Gene. 585(1). 76–83. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Feilan Chen Breakdown of academic impact, for papers by Wang Tang Breakdown of academic impact, for papers by Maya Fakhry Breakdown of academic impact, for papers by Chenchen Ji Breakdown of academic impact, for papers by Karina Galoian Breakdown of academic impact, for papers by Yunshu Che Breakdown of academic impact, for papers by Wanqing Xie Breakdown of academic impact, for papers by Yuning J. Tang Breakdown of academic impact, for papers by Chengyu Lv Breakdown of academic impact, for papers by Yuko Nariai
Rankless by CCL
2026